A tumor vasculature-based imaging biomarker for predicting response and survival in patients with lung cancer treated with checkpoint inhibitors.
Sci Adv
; 8(47): eabq4609, 2022 Nov 25.
Article
in En
| MEDLINE
| ID: mdl-36427313
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Prognostic_studies
/
Risk_factors_studies
Language:
En
Journal:
Sci Adv
Year:
2022
Document type:
Article
Affiliation country:
United States